- Report
- May 2026
- 355 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- May 2026
- 284 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- May 2026
- 179 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- May 2026
- 230 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- May 2026
- 474 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- May 2026
- 590 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- May 2026
- 377 Pages
Global
From €5202EUR$5,850USD£4,500GBP
- Report
- January 2026
- 182 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- January 2026
- 197 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- August 2025
- 185 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- August 2025
- 190 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- August 2025
- 193 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- May 2026
- 180 Pages
Global
From €4002EUR$4,500USD£3,462GBP
- Report
- January 2026
- 181 Pages
Global
From €4002EUR$4,500USD£3,462GBP
- Report
- November 2025
- 186 Pages
Global
From €4002EUR$4,500USD£3,462GBP
- Report
- November 2025
- 181 Pages
Global
From €4002EUR$4,500USD£3,462GBP
- Report
- January 2026
- 192 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- January 2026
- 196 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- January 2026
- 192 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP
- Report
- August 2025
- 197 Pages
Global
From €3153EUR$3,545USD£2,727GBP
€3503EUR$3,939USD£3,030GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more